Human versus mouse PD-1

被引：0
|
作者：
Staicu, Ioana
机构：
[1] Nature Immunology,
来源：
NATURE IMMUNOLOGY | 2025年 / 26卷 / 02期
关键词：
D O I：
10.1038/s41590-025-02086-x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [1] Mouse PD-1 expression and function
    Alaverdi, N
    Iwai, Y
    Honjo, T
    FASEB JOURNAL, 2002, 16 (04): : A710 - A710
  • [2] Regulation of human and mouse bystander T cell activation responses by PD-1
    Le, Catherine T.
    Vick, Logan V.
    Collins, Craig
    Dunai, Cordelia
    Sheng, Michael K.
    Khuat, Lam T.
    Barao, Isabel
    Judge, Sean J.
    Aguilar, Ethan G.
    Curti, Brendan
    Dave, Maneesh
    Longo, Dan L.
    Blazar, Bruce R.
    Canter, Robert J.
    Monjazeb, Arta M.
    Murphy, William J.
    JCI INSIGHT, 2023, 8 (18)
  • [3] Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer
    Bar, Noffar
    Costa, Federica
    Das, Rituparna
    Duffy, Alyssa
    Samur, Mehmet
    McCachren, Samuel
    Gettinger, Scott N.
    Neparidze, Natalia
    Parker, Terri L.
    Bailur, Jithendra Kini
    Pendleton, Katherine
    Bajpai, Richa
    Zhang, Lin
    Xu, Mina L.
    Anderson, Tara
    Giuliani, Nicola
    Nooka, Ajay
    Cho, Hearn J.
    Raval, Aparna
    Shanmugam, Mala
    Dhodapkar, Kavita M.
    Dhodapkar, Madhav V.
    JCI INSIGHT, 2020, 5 (12)
  • [4] Expression and clinical significance of PD-1 in hepatocellular carcinoma tissues detected by a novel mouse anti-human PD-1 monoclonal antibody
    Li, Ziwei
    Li, Bin
    Peng, Dan
    Xing, Haiyan
    Wang, Guanying
    Li, Pan
    Wang, Jiming
    Ye, George
    Chen, Jianhong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 2079 - 2092
  • [5] The PD-1/PD-L1 Pathway in Human Pathology
    Saresella, M.
    Rainone, V.
    Al-Daghri, N. M.
    Clerici, M.
    Trabattoni, D.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (03) : 259 - 267
  • [6] Minimal PD-1 expression in mouse and human NK cells under diverse conditions
    Judge, Sean J.
    Dunai, Cordelia
    Aguilar, Ethan G.
    Vick, Sarah C.
    Sturgill, Ian R.
    Khuat, Lam T.
    Stoffel, Kevin M.
    Van Dyke, Jonathan
    Longo, Dan L.
    Darrow, Morgan A.
    Anderson, Stephen K.
    Blazar, Bruce R.
    Monjazeb, Arta M.
    Serody, Jonathan S.
    Canter, Robert J.
    Murphy, William J.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06): : 3051 - 3068
  • [7] Microanatomical localization of PD-1 in human tonsils
    Iwaia, Y
    Okazaki, T
    Nishimura, H
    Kawasaki, A
    Yagita, H
    Honjo, T
    IMMUNOLOGY LETTERS, 2002, 83 (03) : 215 - 220
  • [8] Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with
    Duan, Wen-Bin
    Wang, Xiao-Hui
    Zhang, Guo-Can
    He, Zhuo
    Li, Shao-Qiang
    Zhou, Jie
    IMMUNOTARGETS AND THERAPY, 2024, 13 : 247 - 258
  • [9] Targeting the PD-1/PD-L1 Axis in Human Vitiligo
    Willemsen, Marcella
    Melief, Cornelis J. M.
    Bekkenk, Marcel W.
    Luiten, Rosalie M.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [10] Generation and characterization of a PD-1 resistant mouse tumor model
    Bernardo, Marie
    Tolstykh, Tatiana
    Zhang, Yu-An
    Bangari, Dinesh
    Cao, Hui
    Lee, Joon Sang
    Malkova, Natalia
    Pollard, Jack
    Sun, Fangxian
    Wiederschain, Dmitri
    Wagenaar, Timothy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345